Evidence map›Paper›PMID 24828816›Full record

ArticlePloS one2014

Tollip or not Tollip: what are the evolving questions behind it?

Denis Prudencio Luiz, Célio Dias Santos Júnior, Ana Maria Bonetti, Malcom Antônio Manfredi Brandeburgo

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Denis Prudencio LuizGenetics Laboratory, Genetics and Biochemistry Institute, Federal University of Uberlandia - UFU, Uberlândia, Minas Gerais, Brazil.
Célio Dias Santos JúniorGenetics Laboratory, Genetics and Biochemistry Institute, Federal University of Uberlandia - UFU, Uberlândia, Minas Gerais, Brazil.
Ana Maria BonettiGenetics Laboratory, Genetics and Biochemistry Institute, Federal University of Uberlandia - UFU, Uberlândia, Minas Gerais, Brazil.
Malcom Antônio Manfredi BrandeburgoGenetics Laboratory, Genetics and Biochemistry Institute, Federal University of Uberlandia - UFU, Uberlândia, Minas Gerais, Brazil.
Universidade Federal de Uberlândia · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tollip plays an important role in the interleukin-1 receptor IL-1R and Toll pathways. As a modulator of the immune pathway, it indirectly controls the amount of antimicrobial peptides. This could indicate a vital step in maintaining animal immune systems and preventing infection. Evolutionary questions are crucial to understanding the conservation and functioning of the biochemical pathways like the Tollip-mediated one. Through an analysis of 36 sequences of the Tollip protein from different animal taxa, downloaded from Kyoto Encyclopedia of Genes and Genomes (KEGG) databank, we inferred diverse evolutionary parameters, such as molecular selection and structure conservation, by analyzing residue by residue, beyond the canonical parameters to this type of study, as maximum likelihood trees. We found that Tollip presented different trends in its evolving history. In primates, the protein is becoming more unstable, just the opposite is observed in the arthropod group. The most interesting finding was the concentration of positively selected residues at amino terminal ends. Some observed topological incongruences in maximum likelihood trees of complete and curated Tollip data sets could be explained through horizontal transfers, evidenced by recombination detection. These results suggest that there is more to be researched and understood about this protein.

Indexed as

Amino Acid SequenceAnimalsDatabases, GeneticEvolution, MolecularIntracellular Signaling Peptides and ProteinsMolecular Sequence DataPhylogenyPrimatesIntracellular Signaling Peptides and Proteins

Identifiers

PMID24828816
PMCPMC4020778
OpenAlexW2105203430

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.